CompletedPhase 2

A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

China89 participantsStarted 2023-11-27

Plain-language summary

This is a multicenter, double-masked, randomized, active-controlled, parallel-comparison study conducted at sites in the China in subjects with Noninfectious Anterior Uveitis

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-70 years at the time providing signed informed consent * At least 1 eye diagnosed with noninfectious anterior uveitis at the time of screening * Willing and able to comply with study requirements and visit schedule Exclusion Criteria: * Diagnosis of intermediate uveitis, posterior uveitis or panuveitis in either eye at the time of screening

What they're measuring

ACC score of ≥2 grade from baseline at Day 14

Timeframe: Day 14

Trial details

NCT IDNCT06679153

SponsorVivaVision Biotech, Inc

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-12-29

View on ClinicalTrials.gov More Anterior Uveitis trials